Issue Archive
|
About Us
|
Contact Us
|
Subscribe
|
Editorial Board
|
Author Guidelines
|
About Haymarket Media
Home
News
Web Exclusives
Daily Oncology News
In the News
New Drug Products
ASH 2011
ASCO 2011
ONS Annual Congress 2011
ASH 2010
CE
CE Articles
mycme.com
Departments
Advisor Forum
Ask a Pharmacist
Case Study
Communication Challenges
From CancerCare
In the News
Issues in Cancer Survivorship
Radiation and Your Patient
Reflections
Stat Consult
The Patient's Voice
The Total Patient
Issue Archive
Topics
Chemotherapy
Communication
End-of-Life Issues
Pain Management
Palliative Care
Radiology
Side-Effect Management
Survivorship
Women's Health
Cancer Types
Brain Cancer
Breast Cancer
Cervical Cancer
Colorectal Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Gynecologic Cancer
Head and Neck Cancer
Kidney Cancer
Leukemia
Liver Cancer
Lung Cancer
Lymphoma
Melanoma
Multiple Myeloma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Sarcoma
Skin Cancer
Chemotherapy Regimens
Clinical Trials
Brain Cancer
Breast Cancer
Cervical Cancer
Colorectal Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Gynecologic Cancer
Head and Neck Cancer
Kidney Cancer
Leukemia
Liver Cancer
Lung Cancer
Lymphoma
Melanoma
Multiple Myeloma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Sarcoma
Skin Cancer
For Your Patient
Advocacy
CancerCare Fact Sheets
Cancer Support Groups
Financial Assistance
Finding Clinical Trials
Palliative Care and Hospice
Patient Information
The Total Nurse
General Medicine in Oncology
Slideshows
Supplements
Jobs
Tools & Links
RSS
|
Login
|
Register
ONA
>
News
> Web Exclusives
Web Exclusives
Side effects of certain cancer drugs may be fatal
Delicia Honen Yard
February 22, 2012
Sorafenib, sunitinib, and pazopanib have been found to carry a heightened risk of fatal complications, but the incidence remains low overall.
High-definition blood test may become comparable to biopsy
Delicia Honen Yard
February 21, 2012
An advanced blood test that detects and analyzes circulating tumor cells provides data that could soon compare to that obtained from biopsies.
Two approaches recommended to reduce oxaliplatin toxicity during colorectal therapy
Delicia Honen Yard
February 20, 2012
A review addresses the need to balance the effectiveness of oxaliplatin against its dose-limiting complication of neurotoxicity.
Diabetes drug reduces cancer mortality
Delicia Honen Yard
February 17, 2012
Cancer patients with diabetes who took metformin were found to have a significantly lower overall mortality than cancer patients without diabetes.
Vaccine used in early breast cancer shows good immunity response
Delicia Honen Yard
February 16, 2012
Many women with early breast cancer experienced a sustained immune response after immunization with a vaccine that fights HER2, and this may reduce their risk for more invasive cancer.
Exercise improves life after cancer treatment
Delicia Honen Yard
February 15, 2012
Physical activity was associated with important positive effects on physical functions and quality of life in persons who had completed their treatment for cancer.
Membrane temperature offers clue to oral mucositis risk in head and neck cancer
Delicia Honen Yard
February 14, 2012
Thermal imaging can detect early changes in the temperature of mucosal surfaces that may signal mucositis in persons with head and neck cancer who are receiving chemoradiotherapy.
MRI can guide nerve-sparing decision in prostate surgery
Delicia Honen Yard
February 13, 2012
The use of preoperative magnetic resonance imaging (MRI) can change the surgical plan for men undergoing surgery for prostate cancer.
HPV self-testing again shows potential screening value
Delicia Honen Yard
February 10, 2012
Another study has shown that human papillomavirus (HPV) testing of self-collected cervicovaginal specimens may be an effective way to screen more women for cervical cancer.
Oxaliplatin improves survival in general colon cancer population
Delicia Honen Yard
February 09, 2012
The survival advantage seen with the addition of oxaliplatin to adjuvant 5-FU was just as evident outside of randomized clinical trials as within.
more »
Subscribe to the RSS for this page [
view all our RSS feeds here
]
Web Exclusives
Side effects of certain cancer drugs may be fatal
Delicia Honen Yard
February 22, 2012
Sorafenib, sunitinib, and pazopanib have been found to carry a heightened risk of fatal complications, but the incidence remains low overall.
High-definition blood test may become comparable to biopsy
Delicia Honen Yard
February 21, 2012
An advanced blood test that detects and analyzes circulating tumor cells provides data that could soon compare to that obtained from biopsies.
Two approaches recommended to reduce oxaliplatin toxicity during colorectal therapy
Delicia Honen Yard
February 20, 2012
A review addresses the need to balance the effectiveness of oxaliplatin against its dose-limiting complication of neurotoxicity.
more »